Literature DB >> 27102500

Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B.

Geffen Kleinstern1, Rania Abu Seir2, Riki Perlman3, Ziad Abdeen4, Areej Khatib5, Husein Elyan6, Eldad J Dann7, Meirav Kedmi8, Martin Ellis9, Arnon Nagler8, Gail Amir10, Dina Ben Yehuda3, Rifaat Safadi11, Ora Paltiel12.   

Abstract

Entities:  

Keywords:  HBV; case-control study; family history; immune response; non Hodgkin lymphoma

Mesh：

Year:  2016        PMID： 27102500      PMCID： PMC5004478          DOI： 10.3324/haematol.2016.144840

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Sophia S Wang; Susan L Slager; Paul Brennan; Elizabeth A Holly; Silvia De Sanjose; Leslie Bernstein; Paolo Boffetta; James R Cerhan; Marc Maynadie; John J Spinelli; Brian C H Chiu; Pier Luigi Cocco; Fiona Mensah; Yawei Zhang; Alexandra Nieters; Luigino Dal Maso; Paige M Bracci; Adele Seniori Costantini; Paolo Vineis; Richard K Severson; Eve Roman; Wendy Cozen; Dennis Weisenburger; Scott Davis; Silvia Franceschi; Carlo La Vecchia; Lenka Foretova; Nikolaus Becker; Anthony Staines; Martine Vornanen; Tongzhang Zheng; Patricia Hartge
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

2.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

3.  Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study).

Authors:  Sarah Krull Abe; Manami Inoue; Norie Sawada; Motoki Iwasaki; Taichi Shimazu; Taiki Yamaji; Shizuka Sasazuki; Yasuhito Tanaka; Masashi Mizokami; Shoichiro Tsugane
Journal:  Cancer Epidemiol       Date:  2015-07-03       Impact factor: 2.984

4.  Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.

Authors:  Nikolaus Becker; Paul Schnitzler; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Yolanda Benavente; Pierluigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-06       Impact factor: 4.553

5.  High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.

Authors:  Feng Wang; Rui-Hua Xu; Bing Han; Yan-Xia Shi; Hui-Yan Luo; Wen-Qi Jiang; Tong-Yu Lin; Hui-Qiang Huang; Zhong-Jun Xia; Zhong-Zhen Guan
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

6.  High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.

Authors:  Fabrizio Marcucci; Alfonso Mele; Enea Spada; Angela Candido; Elvira Bianco; Alessandro Pulsoni; Paola Chionne; Elisabetta Madonna; Rodolfo Cotichini; Anna Barbui; Amalia De Renzo; Fausto Dore; Emilio Iannitto; Vincenzo Liso; Bruno Martino; Marco Montanaro; Livio Pagano; Pellegrino Musto; Maria Rapicetta
Journal:  Haematologica       Date:  2006-04       Impact factor: 9.941

7.  Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations.

Authors:  L Novack; B Sarov; R Goldman-Levi; V Yahalom; J Safi; H Soliman; M Orgel; A Yaari; N Galai; J S Pliskin; E Shinar
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-05-16       Impact factor: 2.184

8.  Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders.

Authors:  Vahap Okan; Mehmet Yilmaz; Aysen Bayram; Cem Kis; Sami Cifci; Hakan Buyukhatipoglu; Mustafa Pehlivan
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

Review 9.  Hepatitis B virus reactivation with rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Joji Shimono; Hiroyuki Ohhigashi; Takanori Teshima
Journal:  World J Hepatol       Date:  2013-11-27

10.  High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.

Authors:  Ming-Huang Chen; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu; Jyh-Pyng Gau; Hao-Wei Teng; Wei-Shu Wang; Ta-Chung Chao; Chueh-Chuan Yen; Po-Min Chen
Journal:  Ann Hematol       Date:  2008-03-08       Impact factor: 3.673
View more
  4 in total

Review 1.  Optimizing antiviral agents for hepatitis B management in malignant lymphomas.

Authors:  Oluwatobi O Ozoya; Julio Chavez; Lubomir Sokol; Samir Dalia
Journal:  Ann Transl Med       Date:  2017-02

2.  Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study.

Authors:  Kefeng Wang; Hang Yang; Wenjun He; Yi Xia; Zhongjun Xia; Su Li; Huiqiang Huang; Zhiming Li; Panpan Liu; Wenqi Jiang
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

3.  Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.

Authors:  Geffen Kleinstern; Rania Abu Seir; Riki Perlman; Areej Khatib; Ziad Abdeen; Husein Elyan; Ronit Nirel; Gail Amir; Asad Ramlawi; Fouad Sabatin; Paolo Boffetta; Eldad J Dann; Meirav Kedmi; Martin Ellis; Arnon Nagler; Dina Ben Yehuda; Ora Paltiel
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

4.  Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study.

Authors:  Yung-Rung Lai; Ya-Lan Chang; Chiu-Hsiang Lee; Tung-Han Tsai; Kuang-Hua Huang; Chien-Ying Lee
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.